CIBC Private Wealth Group
ALXN

CIBC Private Wealth Group’s Alexion Pharmaceuticals ALXN Stock Holding History

CIBC Private Wealth Group’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-72,069
Closed -$11M – 1106
2021
Q1 		$11M Sell
72,069
-86,368
-55% -$13.4M 0.03% 318
2020
Q4 		$24.8M Sell
158,437
-8,051
-5% -$1.03M 0.07% 206
2020
Q3 		$19.1M Sell
166,488
-4,529
-3% -$489K 0.06% 212
2020
Q2 		$19.2M Buy
171,017
+31,598
+23% +$3.35M 0.09% 151
2020
Q1 		$12.5M Buy
139,419
+1,162
+0.8% +$114K 0.05% 219
2019
Q4 		$15M Sell
138,257
-7,414
-5% -$793K 0.05% 238
2019
Q3 		$14.3M Sell
145,671
-3,583
-2% -$404K 0.05% 237
2019
Q2 		$19.6M Buy
149,254
+2,217
+2% +$286K 0.07% 207
2019
Q1 		$19.9M Buy
147,037
+76,815
+109% +$9.55M 0.08% 196
2018
Q4 		$6.84M Sell
70,222
-173
-0.2% -$20.4K 0.03% 307
2018
Q3 		$9.79M Buy
70,395
+59,108
+524% +$7.41M 0.04% 301
2018
Q2 		$1.4M Sell
11,287
-61
-0.5% -$7.13K 0.01% 587
2018
Q1 		$1.26M Buy
11,348
+47
+0.4% +$5.62K 0.01% 602
2017
Q4 		$1.35M Sell
11,301
-28
-0.2% -$3.41K 0.01% 599
2017
Q3 		$1.59M Buy
+11,329
New +$1.54M 0.01% 539

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

CIBC Private Wealth Group's ALXN Position: Q2 2021 in Review

CIBC Private Wealth Group sold out of Alexion Pharmaceuticals (ALXN) in Q2 2021, closing a stake of 72,069 shares — an estimated $11M sold.

CIBC Private Wealth Group first reported a position in ALXN in Q3 2017 and held it in 15 quarters. The position peaked at $24.8M in Q4 2020. 710 funds tracked by Wall St. Rank hold ALXN as of Q2 2021.

  • CIBC Private Wealth Group reported no remaining Alexion Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • CIBC Private Wealth Group sold 72,069 Alexion Pharmaceuticals shares in Q2 2021, an estimated $11M.
  • CIBC Private Wealth Group first reported a position in Alexion Pharmaceuticals in Q3 2017 and held it in 15 quarters.
  • CIBC Private Wealth Group's Alexion Pharmaceuticals position peaked at $24.8M in Q4 2020.
  • 710 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2021.

Based on CIBC Private Wealth Group's 13F filing for Q2 2021, filed 16 Aug 2021.